According to a recent LinkedIn post from Infinity Bio Inc, the company plans to participate in IMMUNOLOGY2026 in Boston and exhibit at Booth 418. The post highlights its focus areas of antibody reactome profiling, antigen display technology, and immune history mapping, and notes that representatives will be on site from April 15–19.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Infinity Bio is seeking deeper engagement with the global immunology community and potential customers or collaborators in its niche technology domains. For investors, this presence at a major scientific meeting may indicate continued business development efforts and could help the company refine partnerships, expand its customer pipeline, and strengthen its positioning in specialized immunology research tools and platforms.